Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

2 Feb 2018 07:00

RNS Number : 7140D
CATCo Reinsurance Opps Fund Ltd
02 February 2018
 

 

 

 

CATCo Reinsurance Opportunities Fund Ltd. ("the Company")

Portfolio Update

 

To: SFM, London Stock Exchange and Bermuda Stock Exchange

Date: 2 February, 2018

 

2018 Portfolio Highlights

· As a result of the 2017 catastrophic events and increases in rates, the 2018 portfolio indicative maximum net return is approximately 23 percent on invested capital (c. 43 percent greater than the 2017 portfolio maximum net returns of 16 percent). These figures are all net of hedging costs.

· The maximum capital exposed to a worst-case single event is limited to 8 percent for the 2018 portfolio, compared to 10 percent for the 2017 portfolio.

· Continued increased demand for Markel CATCo Re Ltd. (the "Reinsurer") products has led to 100 percent of available capital being deployed at 1 January 2018.

 

2017 Portfolio Summary

· 2017 net asset value ("NAV") return for the Ordinary shares was -27.6 percent.

· Loss reserves were implemented in an amount as a percent of 1 January 2017 NAV as follows:

o Hurricanes Harvey, Irma and Maria: c. 28.6 percent (net of recoveries on hedges);

o California Wildfires: c. 17 percent;

o Mexico Earthquakes, Cyclone Debbie, US Convective Storms: c. 2 percent.

· The total Side Pocket Investments ("SPI's") held at 31 December 2017 by calendar year of underwriting are as follows as a percentage of the Company's 1 January 2017 NAV:

o 2015: c. 1.2 percent (c. 3.2 percent of Ordinary shares at 31 December 2016);

o 2016: c. 6.1 percent (c. 7.1 percent of Ordinary and C shares at 31 December 2016);

o 2017: c. 41.5 percent.

· The 2017 annual dividend was announced on 31 January 2018. Annual dividends of $0.05476 in respect of each of the Ordinary shares will go ex-dividend on 8 February 2018. It is expected that this dividend will be paid to Ordinary shareholders on 26 February 2018.

· After reflecting 2017 SPIs and loss reserves, the Ordinary shares, post dividend, will have c. 35 percent of NAV available for reinvestment in the 2018 portfolio.

· Since inception (incl. the aforementioned dividend), the Company has returned capital of $234m to Ordinary and C share investors by way of dividends and return of value distributions. The original Ordinary Shareholders from December 2010 have received approximately 75% of their original investment through such distributions.

 

 

For further information:

Judith Wynne

General Counsel

Markel CATCo Investment Management Ltd.

Telephone: +1 441 493 9005

Email: judith.wynne@markelcatco.com

 

Mark Way

Chief Operating Officer

Markel CATCo Investment Management Ltd.

Telephone: +1 441 493 9001

Email: mark.way@markelcatco.com

 

David Benda / Hugh Jonathan

Numis Securities Limited

Telephone: +44 (0) 20 7260 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUDDGDDRBGBGIB
Date   Source Headline
12th Jun 20067:00 amRNSRule 8.3- Cambridge Antibody
9th Jun 20061:30 pmRNSRule 8.3- (CAT)
9th Jun 200612:36 pmRNSEPT Disclosure
9th Jun 200611:56 amRNSEPT Disclosure
9th Jun 200611:54 amRNSEPT Disclosure
9th Jun 200611:38 amRNSRule 8.3-Cambridge Antibody
8th Jun 20064:19 pmRNSRule 2.10 Announcement
8th Jun 20062:21 pmRNSEPT Disclosure
8th Jun 20061:14 pmRNSRule 8.3- (CAT)
8th Jun 200610:49 amRNSEPT Disclosure
7th Jun 20065:01 pmRNSHolding(s) in Company
7th Jun 20064:55 pmRNSRule 8.3- Cambridge Anti Tech
7th Jun 200612:38 pmRNSRule 8.3- (CAT)
7th Jun 200612:08 pmRNSEPT Disclosure
7th Jun 200610:00 amRNSOffer for Cambridge Antibody
6th Jun 20064:01 pmRNSRule 8.3- Cambridge Antibody
6th Jun 20063:45 pmRNSRule 8.3- Cambridge Antibody
6th Jun 200612:43 pmRNSEPT Disclosure
5th Jun 20066:00 pmRNSEPT Disclosure
5th Jun 20061:10 pmRNSRule 8.3- (CAT)
5th Jun 200612:55 pmRNSEPT Disclosure
5th Jun 200611:24 amRNSEPT Disclosure
2nd Jun 20062:14 pmRNSEPT Disclosure
2nd Jun 20061:19 pmRNSRule 8.3- (CAT)
2nd Jun 200612:27 pmRNSEPT Disclosure
2nd Jun 200612:22 pmRNSEPT Disclosure
2nd Jun 20067:00 amRNSRule 8.3- Cambridge Antibody
1st Jun 20064:22 pmRNSRule 8.3- Cambridge Antibody
1st Jun 20063:21 pmRNSHolding(s) in Company
1st Jun 200612:25 pmRNSEPT Disclosure
1st Jun 200611:10 amRNSEPT Disclosure
31st May 20063:13 pmRNSRule 8.3- (CAT)
31st May 20063:00 pmRNSMerger Update
31st May 20061:04 pmRNSRule 8.3- Cambridge Antibody
31st May 200611:43 amRNSEPT Disclosure
31st May 200611:27 amRNSEPT Disclosure
31st May 200611:25 amRNSEPT Disclosure
30th May 20063:25 pmRNSRule 8.3- (CAT)
30th May 20063:16 pmRNSEPT Disclosure
30th May 200611:49 amRNSEPT Disclosure
30th May 200610:29 amRNSEPT Disclosure
26th May 20062:26 pmRNSEPT Disclosure
26th May 20061:28 pmRNSRule 8.3- (CAT)
26th May 200611:20 amRNSEPT Disclosure
26th May 200610:55 amRNSEPT Disclosure
26th May 200610:05 amRNSRule 8.3- (CAT)
26th May 200610:03 amRNSRule 8.3- (CAT)
26th May 200610:02 amRNSRule 8.3- (CAT)
26th May 200610:00 amRNSRule 8.3- (CAT)
25th May 20063:49 pmRNSRule 2.10 Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.